Fibryga (fibrinogen concentrate (human)) / Octapharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fibryga (fibrinogen concentrate (human)) / Octapharma
FORMA-02, NCT02267226 / 2011-002419-27: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

Completed
3
25
Europe, US, RoW
Octafibrin
Octapharma
Congenital Fibrinogen Deficiency
02/18
02/18
FIBRES, NCT03037424: FIBrinogen REplenishment in Surgery

Completed
3
827
Canada
Octafibrin, Cryoprecipitate
University Health Network, Toronto
Deficiency; Fibrinogen, Acquired
11/18
03/19
FORMA-04, NCT02408484 / 2014-005115-16: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

Completed
3
15
RoW
Octafibrin, Fibrinogen concentrate
Octapharma
Congenital Fibrinogen Deficiency
06/19
06/19

Download Options